Business Wire

Elucid’s PlaqueIQ™ Image Analysis Software Included in EviCore Coverage Guidelines

BOSTON--(BUSINESS WIRE)--Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, today ...
Morningstar

Elucid Launches PlaqueIQ Image Analysis Software for the Carotid Arteries

The first and only CT-based plaque analysis indicated for the carotid anatomy that can help physicians assess risk of rupture and ischemic stroke 1 Elucid, an AI medical technology company focused on ...
Business Wire

Elucid Receives U.S. 510(k) Clearance of PlaqueIQ™ Image Analysis Software to Aid Cardiovascular Disease Assessment

BOSTON--(BUSINESS WIRE)--Elucid has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its PlaqueIQ™ imaging analysis software to help physicians diagnose ...
Healio

FDA clears software to reduce ‘guesstimation’ when assessing atherosclerotic risk

Please provide your email address to receive an email when new articles are posted on . The FDA cleared a semiautomated software to aid in plaque visualization and classification. The AI-assisted ...
Morningstar

Elucid Appoints Dr. Robert Pelberg as New Senior Vice President of Medical Affairs

Cardiac CT Expert to Advance Research and Commercialization of Company’s PlaqueIQTM Image Analysis Software Elucid, an AI medical technology company focused on providing physicians with a more precise ...